GO:0004713 protein tyrosine kinase activity

Protein tyrosine kinase activity (GO:0004713) is a fundamental enzymatic molecular function in eukaryotic signal transduction. It is defined by the Gene Ontology as the catalysis of the reaction ATP + a protein tyrosine = ADP + protein tyrosine phosphate, meaning that an enzyme transfers the terminal phosphate of ATP onto the hydroxyl group of a tyrosine residue within a protein substrate. This modification, termed tyrosine phosphorylation, is a reversible post-translational event that creates a specific binding surface for proteins containing SH2 or PTB domains, thereby propagating intracellular signals. The first membrane receptors with intrinsic protein-tyrosine kinase activity were described in the 1980s, establishing the paradigm of growth factor receptor signaling. Since then, PTKs have been recognized as central regulators of cell proliferation, differentiation, survival and metabolism. Researchers study GO:0004713 because it sits at the apex of many oncogenic and immune signaling pathways. Receptor tyrosine kinases such as the epidermal growth factor receptor (EGFR) possess an intrinsic PTK domain that becomes activated upon ligand binding, and purified EGFR kinase domains can autophosphorylate and phosphorylate exogenous substrates in vitro. Non-receptor PTKs, including SYK and JAK3, mediate signaling from immunoreceptors and cytokine receptors, respectively. The activity of these enzymes is tightly controlled by reversible phosphorylation and dephosphorylation events, as demonstrated for a rat lung protein tyrosine kinase whose activity is modulated by phosphorylation. Because PTK activity is frequently deregulated in cancer and inflammatory diseases, it remains one of the most intensively pursued target classes in biomedical research. This article provides a research-grade overview of GO:0004713, covering its definition, catalytic mechanism, key genes, regulatory features, disease links and the CRISPR-based experimental models used to interrogate it. All statements are grounded in the verified literature cited by number.

In the Gene Ontology, GO:0004713 protein tyrosine kinase activity is a molecular function defined as the catalysis of the reaction ATP + a protein tyrosine = ADP + protein tyrosine phosphate. In practical terms, an enzyme annotated with this term binds ATP and a protein substrate containing a tyrosine residue, transfers the gamma-phosphate of ATP to the tyrosine hydroxyl group, and releases ADP and a phosphotyrosine-containing protein product. This activity is intrinsic to both receptor tyrosine kinases, such as EGFR, and non-receptor tyrosine kinases, such as SYK, SRC and JAK3. The synonym protein-tyrosine kinase activity is used interchangeably.

Protein tyrosine kinase activity is one of the most consequential molecular functions in metazoan biology because it converts extracellular and intracellular cues into phosphotyrosine-based signals that control cell fate. Receptor PTKs such as EGFR transmit growth factor signals across the plasma membrane, while non-receptor PTKs such as SYK and JAK3 relay immunoreceptor and cytokine receptor signals. The same activity also intersects with G protein-coupled receptor pathways, broadening its regulatory reach. Because excessive or constitutive PTK activity drives oncogenesis and immune dysregulation, this GO term is directly relevant to drug discovery, biomarker development and functional genomics.

The following genes encode representative protein tyrosine kinases or closely related regulators that are commonly studied in the context of GO:0004713.

Protein tyrosine kinase activity is regulated at multiple levels. Reversible phosphorylation and dephosphorylation directly modulate catalytic activity, as demonstrated for a rat lung protein tyrosine kinase whose activity is controlled by phosphorylation/dephosphorylation cycles. Autophosphorylation of the activation loop stabilizes the active conformation of receptor PTKs such as EGFR. Non-receptor PTKs can be regulated by other kinases; for example, PTK6 regulates activation of SRC kinase, and protein kinase A can activate canonical tyrosine kinase signaling pathways. Protein tyrosine phosphatases provide an opposing regulatory layer by removing phosphotyrosine marks. In addition, G protein-coupled receptor signaling can intersect with PTK-mediated pathways, adding further regulatory complexity.

Constitutive activation of protein tyrosine kinases is a well-established oncogenic mechanism. Receptor PTKs such as EGFR can drive proliferative signaling when mutationally activated or overexpressed. Non-receptor PTKs including SRC and PTK6 contribute to tumor progression, and PTK6 regulates SRC activation, linking two oncogenic kinases. Because phosphotyrosine signaling promotes survival and proliferation, PTK inhibitors have become a major class of anticancer drugs.

SYK and JAK3 are non-receptor PTKs essential for immunoreceptor and cytokine receptor signaling, respectively. JAK3 PTK activity mediates interleukin-7-induced activation of phosphatidylinositol-3-kinase, a pathway critical for lymphocyte development and function. Dysregulation of these kinases can lead to immunodeficiency or autoimmune pathology, making them attractive targets for immunomodulatory therapy.

Protein kinase A can activate canonical tyrosine kinase signaling pathways to promote granulosa cell differentiation, indicating that PTK activity participates in endocrine regulation of ovarian function. This illustrates that PTK signaling is not limited to growth factor and immune contexts but also operates in reproductive physiology.

Purified kinase domains or immunoprecipitated PTKs can be incubated with ATP and substrate proteins, and the incorporation of phosphate into tyrosine residues is measured using radiolabeled ATP or anti-phosphotyrosine antibodies. This approach was used to demonstrate activation of the purified EGFR kinase domain and to study regulation of a rat lung PTK by phosphorylation/dephosphorylation.

Mass spectrometry-based phosphoproteomics enables global mapping of tyrosine phosphorylation sites generated by PTK activity. By comparing wild-type and PTK-knockout cells, researchers can identify direct and indirect substrates. This is particularly useful for non-receptor PTKs such as SYK and JAK3, whose substrates overlap with immune signaling networks.

CRISPR knockout, point mutation, knock-in and overexpression models allow causal testing of PTK function. For example, knockout of PTK6 can reveal its role in SRC activation, while point mutations in the EGFR kinase domain can distinguish kinase-dependent from kinase-independent functions. These models are complemented by RNA-seq and phosphoproteomics to define downstream pathways.

Reporter assays, calcium flux measurements and PI3K activity assays can quantify PTK-dependent signaling. JAK3 PTK activity was linked to interleukin-7-induced phosphatidylinositol-3-kinase activation using such approaches. G protein-coupled receptor crosstalk with PTK pathways can also be interrogated with second-messenger reporters.

Researchers studying protein tyrosine kinase activity-related genes often need to determine whether a candidate gene is causally involved in a signaling pathway or disease phenotype. EDITGENE provides a comprehensive suite of CRISPR-based services to generate precisely engineered cell models that answer these questions.

Protein tyrosine kinase activity (GO:0004713) is a central molecular function that converts ATP into a phosphotyrosine signal on protein substrates, driving diverse cellular responses. Its dysregulation underlies cancer, immune disorders and other pathologies, making it a prime target for research and therapeutic intervention. Understanding the mechanisms, key genes and regulatory layers of PTK activity requires robust experimental models. CRISPR-based knockout, point mutation, knock-in and overexpression approaches, combined with phosphoproteomics and bioinformatics, provide the tools needed to dissect this activity in health and disease.